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Researchers identify enzyme that 
may play role in Alzheimer's disease 
In a study presented at the seventh International Symposium on 
Amyloidosis, School of Medicine researchers have identified an 
enzyme that may play a role in the formation of senile plaques in 
the brain of patients with Alzheimer's disease. These plaques 
are formed when a large protein, the amyloid precursor protein 
(APP), is broken down into a smaller protein, the amyloid beta 
protein. 
The medhanism responsible for the breakdown of APP is vir-
tually unknown, but, in this in vitro study, a protease from a 
brain with Alzheimer's disease was shown to break down a key 
bond between two amino acids, methionine and aspartic acid, in 
the amyloid precursor protein. 
According to Carmela Abraham, PhD, an associate professor 
of medicine and biochemistry, and Gregory Papastoitsis, PhD, a 
postdoctoral fellow, these findings suggest that this protease may 
be initiating the first step in the degradation of APP, but that in 
vivo studies are needed to determine whether it actually plays a 
role in Alzheimer's disease. 
The researchers have found that the protease did not degrade 
other common proteins, which suggests that it is specific to the 
amyloid precursor protein. The scientists are developing antibod-
ies against this protease that will allow them to determine how it 
is distributed in the body. The group is also developing ways to 
block the production of the protease to prove whether it is, as 
they suspect, actually involved in Alzheimer's disease. 
Lack of activity, television, tied 
to high body fat in preschoolers 
Two School of Medicine investigations, both using data from the 
Boston University Framingham Children's Study, have identi-
fied separate predictors of body fat in early childhood. 
In the first study, researchers have found that low levels of ac-
tivity during the preschool years may predict an increase in body 
fat in early childhood. In this investigation of 103 preschool-age 
children, led by Lynn L. Moore, DSc, an assistant professor of 
medicine, the researchers used electronic body motion sensors at-
tached to the children's waists to measure their activity for two 
five-day periods each year. The children were studied for a 
mean time of two-and-a-half years. At annual clinic visits, the 
researchers used a skinfold test to measure the subcutaneous fat 
in the children's triceps. Triceps skinfolds are considered the 
best measure of body fat percentage in young children and these 
measurements are expected to decrease in the preschool years as 
children lose their baby fat. In this study, however, Moore found 
that children with a low level of activity showed an increase in 
body fat compared to children with higher levels of activity. 
Incoming students were welcomed at a reception sponsored by the 
Alumni Association on Sept. 2. Pictured, Paul M. O'Bryan, PhD, left, 
an associate professor of physiology, talks with first-year students Ari 
Schwartz, Amiel Levin, Elaine Melamud and Andra Davis, (photo by 
David Herwaldt) 
In the second study, led by Munro H. Proctor, MD, MPH, an 
associate clinical professor of medicine, researchers followed the 
television viewing habits of preschool children for four years. 
They found that the more hours of television a child watched, the 
greater the increase in body fat. The amount of television 
viewed may be an indirect measure of physical activity. 
"We are concerned about activity levels in the preschool 
years not only because they relate to the risk of childhood obe-
sity but because activity levels tend to be fairly stable over 
time," said Moore, who also contributed to the second study. 
She added that other studies have shown that if children are not 
active by late elementary school, they are very unlikely to ever 
be active as adults. Moore said that future studies will examine 
whether other factors in elementary school can influence activity 
levels. 
Samet awarded one of 15 national 
RWJ Faculty Scholars grants 
Jeffrey H. Samet, MD, MPH, an assistant professor of medicine, 
was one of 15 physicians across the country to receive four-year 
Generalist Physician Faculty Scholars grants from the Robert 
Wood Johnson Foundation, the nation's largest health care phi-
lanthropy. 
The grant, part of a wide-ranging effort to counter a nation-
wide shortage of primary care physicians, is aimed at assisting 
the career development of generalist medical school faculty 
members. Grant recipients will conduct research related to gener-
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alist medicine and serve as role models to medical students con-
templating careers in general internal medicine, pediatrics or fam-
ily medicine. 
The grants are based in part on a recent study that showed that 
one of the most important factors influencing medical students' 
choice of medical paths is exposure to top-notch faculty mem-
bers who are both researchers and clinicians. The perception of 
generalist medicine as a non-academic specialty may lead them 
to choose careers in other areas of medicine, some experts be-
lieve. It is the purpose of the grant to allow generalists to engage 
in research while maintaining their clinical expertise. 
Samet plans to use the grant to study ways in which care-
providers can tailor outreach efforts to certain HIV-infected popu-
lations, in order to get them to seek treatment earlier. Through 
his work in setting up a diagnostic evaluation unit at Boston City 
Hospital, Samet has found that many people with HIV do not 
seek treatment for years after acquiring the infection. 
Samet will be exploring whether a person's decision to seek 
treatment is based primarily on the amount of emotional support 
available at home; whether the person is depressed; the severity 
of an alcohol or drug addiction, and the extent to which the per-
son is comfortable with the medical system. In addition to seek-
ing ways to target these people, Samet hopes to develop ways to 
improve patients' adherence to prescribed medical regimens. 
Two exchange students recently arrived at the School of Medicine to 
participate in the BUSMIHebrew University-Hadassah Medical School 
Faculty!Student Exchange Program, which is now in its eighth year. The 
exchange students. Tali Green and Oren Shibolet, will take part in three 
rotations at Boston City Hospital and Boston University Medical Center 
Hospital. 
Pictured at a luncheon to honor last year's exchange students are, 
from left, Asher Yarden, Israeli consul; Dean Emeritus John I. Sandson; 
Joseph J. Vitale, MD, ScD, a professor of pathology; exchange students 
Uri Tabori and Hillel Greisner; Louis Kaitz, benefactor of the exchange 
program; Leonard S. Gottlieb, MD, MPH, chairperson of pathology and 
laboratory medicine and director of the exchange program; Dean Aram 
V. Chobanian; Charlotte Kaitz, benefactor of the exchange program; As-
sociate Dean Emeritus Ernest Blaustein, and Edward Alexander, MD, a 
professor of medicine and a research professor of physiology, and asso-
ciate director of the exchange program. Both Blaustein and Sandson 
are members of the exchange program's advisory committee. 
Progress shown in development of 
biocompatible synthetic cornea 
Two experiments to determine the biologic response to materials 
used in synthetic corneas have shed some light on a persistent 
problem: how to induce the body's own tissue to grow and hold 
the synthetic material in place. 
In one in vitro experiment, Vickery Trinkaus-Randall, PhD, 
an assistant research professor of ophthalmology, was able to in-
duce the growth of corneal epithelial cells on the transparent hy-
drogel in the center of the synthetic cornea. Epithelial cells 
normally cover the outside of a natural cornea to protect it, mak-
ing it smooth and allowing light to pass through it. The re-
searcher also observed that the new cells became confluent, or 
grew together, and began to make proteins critical to establishing 
a basement membrane on which the epithelium could be an-
chored. 
In another experiment, Trinkaus-Randall successfully used 
amines, organic compounds derived from ammonia, to mimic the 
electrical charges normally found in extracellular matrix proteins 
to induce cellular growth. The development of a synthetic cor-
nea that could be used to replace a patient's own diseased cornea 
has long been of concern to scientists. While corneal transplants 
are common in the United States, many countries, particularly de-
veloping nations, do not perform corneal transplants for cultural 
reasons or because OLLconcems^bout infectious diseases. 
Researcbers propose model for 
bow some tranquilizers may work 
Although most drugs work by substituting for, or blocking the ac-
tivities of, endogenous substances, others, such as Valium and 
Librium, act as allosteric modulators that change the shape of cer-
tain receptors in the brain and thereby affect the way these recep-
tors react to their chemical signals. Modulation is poorly 
understood, however, and has been of limited use as a basis for 
pharmacological design. School of Medicine researchers, how-
ever, have proposed a model for modulation that may explain 
how existing modulators work, and could also aid in the design 
of new pharmacological modulators. The researchers are David 
Farb, PhD, chairperson of the Department of Pharmacology and 
Experimental Therapeutics, and Terrell T. Gibbs, PhD, an assis-
tant professor of pharmacology and experimental therapeutics. 
According to Gibbs, who recently presented the research at 
the "Macromolecules, Genes and Computers: Chapter III" meet-
ing in New Hampshire, allosteric modulators work by binding to 
receptors when they are in the active, rather than the inactive, 
state. Although these modulators are too weak to tum receptors 
on by themselves, they can, in effect, help the natural neurotrans-
mitter to pull other receptors into an active state. The receptors 
then open a sort of macromolecular "gate" and allow the body's 
own electrical signals to enter. 
As Gibbs points out, however, work in this area is still very 
preliminary: Scientists do not know what it is about a drug bind-
ing to a receptor that would cause it to open its gate, and, so far, 
technologies such as x-ray crystallography, nuclear magnetic 
resonance and computer modeling have yielded very few an-
swers. 
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Seminars on interdisciplinary perspectives 
in biotechnology to be held 
Boston University Schools of Public Health, Medicine, Engineer-
ing, Law and Philosophy have joined together to present "Interdis-
ciplinary Perspectives in Biotechnology," a series of four 
seminars being held on the Charles River Campus. The first, ti-
tled "Genetic Screening under a National Health Care Program," 
was held on Oct. 15 and featured SPH faculty Wendy K. Mariner, 
JD, MPH, George J. Annas, JD, MPH, and Michael Grodin, MD, 
EAAP. 
The following is a list of upcoming seminars, each of which 
will be held from 9 to 11 a.m. at Barrister's Hall in the School of 
Law, 765 Commonwealth Ave. 
On Nov. 19, a seminar titled "Genetic Privacy: Rules for Gene 
Banks" will be led by Annas and Grodin. 
On Feb. 18, David Pollen, MD, a professor of neurology at the 
University of Massachusetts Medical Center, will present "Han-
nah's Heirs: The Quest for the Genetic Origins of Alzheimer's 
Disease." 
On March 18, a program on "Biodiversity and the Biotechnol-
ogy Business" will feature Sheldon Krimsky, PhD, chairperson of 
the Department of Urban and Environmental Policy at Tufts Uni-
versity, and Rollin Johnson, PhD, from the Center for Science 
and International Affairs at Harvard University's Kennedy 
Sehool of Government. „ _ 
For more information, contact the SPH's Law, Medicine and 
Ethics Program at x8-4626 (638-4626). 
Scbool of Medicine students appointed 
to AMSA leadersbip positions 
Three School of Medicine students have been appointed to na-
tional leadership positions with the American Medical Student 
Association (AMSA). Giuseppe Ciaravino '95 has been named 
an associate trustee to the National Board of Trustees; Souman 
Nandy '96 has been appointed as the co-coordinator of the Na-
tional Computers in Medicine Task Force, and Mathieu 
Bermingham '96 has been appointed co-coordinator of the Na-
tional Medical Education Standing Committee. 
Founded in 1950, the AMSA is the largest independent, na-
tional organization developed and governed by medical students. 
AMSA has over 30,000 members, 154 chapters, 16 pre-med chap-
ters and four affiliate foreign chapters. The officers of the School 
of Medicine AMSA chapter are John Udarbe '96, president, 
Chrysanthe Gaitatzes '96, recruitment coordinator, and Deborah 
Martin '96, Task Force/Standing Committee liaison. 
Dept. of Pbarmacology announces 
seminar scbedule for Nov., Dec. 
The following is a list of upcoming seminars sponsored by the 
Department of Pharmacology and Experimental Therapeutics. 
Each program will be held from 3:30 to 4:30 p.m. in Room 603 
of the Instructional Building and will be preceded by refresh-
ments beginning at 3:15 p.m. 
A reception was held on Sept. 20 to honor the 20-year tenure of Daniel 
Bernstein, MD, associate dean for resources and hospital affiliations. 
Bernstein recently retired from the School of Medicine. 
Bernstein first came to the School of Medicine in 1973 as an associ-
ate clinical professor of medicine. In 1977, he was named a clinical 
professor of medicine and, in 1980, was appointed an associate dean. 
Pictured at the reception, Bernstein, left, greets Carl Apstein, MD, a 
professor of medicine and a research professor of physiology, (photo by 
Lucy Milne, BUSM Educational Media Support Center) 
On Nov. 17, Richard A. Cohen, MD, a professor of medicine, 
will present "Role of the Endothelium and Potassium Channels 
in Vascular Reactivity." 
On Dec. 1, Keith Miller, PhD, of the Department of Anesthe-
sia at Harvard Medical School and Massachusetts General Hospi-
tal, will present "Mechanisms of Action of General Anesthetics 
on Acetylcholine Receptors." 
On Dec. 8, "Dopaminergic Regulation of the Endogenous 
Opioid System" will be presented by Ellen Unterwald, PhD, 
from the Laboratory of the Biology of Addictive Diseases at 
Rockefeller University. 
Briefly noted 
Harold L. Lazar, MD, an associate professor of cardiothoracic 
surgery, was recently appointed secretary of the Section of Car-
diac Surgery of the American College of Chest Physicians 
(ACCP)....Marianne Front, MD, an associate professor of medi-
cine and a co-founder of BUMC Hospital 's Breast Health Center, 
recently participated in a Senate field hearing on women's health 
concerns. The hearing, titled "Improving Women's Health 
through Early Detection and Prevention Efforts," focused on 
breast and cervical cancer screening, injury control, violence pre-
vention and sexually transmitted diseases. Held at Simmons Col-
lege, the hearing was chaired by Sen. Edward M. Kennedy. 
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Upcoming CME courses 
The following is a list of upcoming courses sponsored by the De-
partment of Continuing Medical Education. 
On Nov. 6 a seminar titled "Topics for the Practicing Pediatri-
cian: Issues for the 1990s" will be held at the Sonesta Hotel in 
Cambridge. 
The New England Cancer Society's Annual Meeting will take 
place from Nov. 12 through Nov. 14 at the Colonnade Hotel in 
Boston. 
The Eighth Annual Smithwick Symposium, titled "Chal-
lenges in Trauma Care," will be held on Nov. 19 at Boston Uni-
versity Medical Center. 
"Current Clinical Pediatrics" is the topic for a seminar that 
will be held from Dec. 28 through Dec. 30 at the Buena Vista 
Palace in Walt Disney World, Orlando, Ela. 
For further information contact the Department of Continuing 
Medical Education at x8-4605 (638-4605). 
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